NEW YORK (Reuters Health) – Testing for autoantibody against the 155-kDa protein is a “highly accurate” tool for diagnosing cancer-associated myositis in adults with dermatomyositis, according to a…
NEW YORK (Reuters Health) – The Oncotype DX test, based on reverse transcription polymerase chain reaction (RT-PCR), for HER2 gene amplification in breast cancers has an “unacceptable” false-negative…
NEW YORK (Reuters Health) – Laparoscopic partial nephrectomy (LPN) and laparoscopic cryoablation (LCA) are viable nephron-sparing options for patients with a small tumor in a solitary kidney, researchers…
NEW YORK (Reuters Health) – In patients with indolent non-Hodgkin’s B-cell lymphoma, a more intensive regimen of rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) does not prompt…
NEW YORK (Reuters Health) – BRCA2, but not BRCA1, gene mutation is associated with improved survival and response to chemotherapy in women with high-grade serous ovarian cancer, an…
NEW YORK (Reuters Health) – In advanced renal cell cancer, targeted inhibitors of the vascular epithelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pathways improve progression-free…
NEW YORK (Reuters Health) – In patients with cardiac tamponade, extended drainage using a pericardial catheter versus simple pericardial drainage reduces the likelihood of recurrence, according to study…
NEW YORK (Reuters Health) – The American Society of Clinical Oncology (ASCO) has updated its recommendations for the use of antiemetics during cancer treatment, and one key change…
NEW YORK (Reuters Health) – Among children receiving anthracycline-based chemotherapy, echocardiograms obtained before and during treatment rarely detect significant cardiotoxicity that changes treatment decisions, reports a team with…
NEW YORK (Reuters Health) – Cancer patients who develop febrile neutropenia after chemotherapy but who are otherwise stable can be treated as outpatients, with no greater risk for…